Next Gen Video Meets Reality at IBC2018
Technology companies and service providers will once again come together to discuss the latest trends, strategies and developments in online TV and video at the Content Everywhere Hub programme at IBC2018, it has been announced today. As the latest addition to the agenda for IBC2018, the world’s most influential media, entertainment and technology show (to be held from 13-18 September at the RAI in Amsterdam), the IBC Content Everywhere Hub will consist of 10 expert panel discussions and 34 product demos.
Situated at the heart of IBC2018 in Hall 14, IBC Content Everywhere combines a high-quality exhibition with the Hub programme designed to help visitors learn and experience how innovative new technologies are expanding the opportunities arising from the exponential growth of content consumption online.
The agenda for the Hub is centered on 10 panel discussions drawing together a range of perspectives and expertise on key issues including the implications for the digital media sector of high profile emerging technologies such as 5G, Edge computing and blockchain. Other topics covered will include how to successfully grow an OTT service, how artificial intelligence and machine learning are impacting content creation, OTT distribution and monetisation, new business models and innovations in programmatic advertising, as well as the convergence of broadcast and telecoms.
There will also be 34 product demonstrations covering the entire OTT distribution chain, including online video platforms, transcoding and streaming solutions, content security options and monetisation techniques. Speakers will include experts from small start-ups to some of the biggest names in technology including Google, Alibaba, CSGi, Telia, Ooyala and Roku.
With viewers wishing to take greater control over their viewing habits, over-the-top distribution is becoming more and more critical to the electronic media eco-system. Offering consumers ‘content everywhere’ and catch-up services are now essential requirements for many broadcasters to complement traditional distribution, as well as telcos wanting to add video to their portfolios or independent content creators or brands wishing to go direct-to-consumer. The ability to deliver content ‘over the top’ across broadband networks has also opened the door for new players to establish their own direct relationships with new audiences. IBC Content Everywhere will bring together technology companies and service providers who are at the heart of this revolution
## ENDS ##
Notes to Editors:
For more information about IBC2018 visit: show.ibc.org
About IBC
IBC is the world’s most influential media,
entertainment and technology show, attracting 57,000+ attendees from
more than 170 countries and combining a highly respected and
peer-reviewed conference with an exhibition that showcases 1,700+
leading industry suppliers of state-of-the-art technology. In addition
to the world-class exhibition and conference, IBC also encompasses the
IBC Daily, IBCTV and IBC365.
IBC365 provides year-round insight and opinion into the hot topics and key trends from leading industry journalists, along with insightful whitepapers, peer reviewed technical papers, highly engaging webinars and an expansive video library.
IBC2018 Dates
Conference: 13 - 17 September 2018
Exhibition:
14 - 18 September 2018
For more information about IBC2018 visit: show.ibc.org/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180802005310/en/
Contact information
IBC
Louise Wells, Bubble Agency
E: louisew@bubbleagency.com
T:
+44 7718 985 252
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Azafaros to Present at BIO International Convention 2025 Following Successful €132M Series B Financing9.6.2025 08:00:00 EEST | Press release
Azafaros, a clinical-stage biotechnology company developing novel therapies for rare lysosomal storage disorders (LSDs), today announced that it will present at the 2025 BIO International Convention taking place in Boston, USA, from 16-19 June. The company’s presentation is scheduled for Monday, June 16 at 16:45 ET in Room 153B. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses and Niemann-Pick disease type C (NPC). This announcement follows Azafaros’ recently completed and oversubscribed €132 million Series B financing round, which will support advancing nizubaglustat into pivotal clinical development. The company is on track to initiate two Phase 3 trials in GM1/GM2 gangliosidoses and NPC in 2025. Earlier this year, Azafaros reported positive topline results from its ongoing Phase 2 study evaluating n
A-CAP Announces Successful Divestiture of Standard de Liège SA and Immobilière du Standard de Liège SRL6.6.2025 23:32:00 EEST | Press release
Advantage Capital Holdings, LLC (“A-CAP” or “The Company”), a New York-based insurance and financial services company with over $12 billion in assets, today announced the successful divestiture of Standard de Liège SA (“Standard Liège” or the “Club”), one of Belgium's most historic soccer clubs, and Immobilière du Standard de Liège SRL, the corporate entity that owns the Club's stadium, Maurice Dufrasne Stadium, to a consortium of buyers led by Standard Liège Chief Executive Officer Giacomo Angelini. This transaction marks the end of 777 Partners’ legacy involvement with the Club and sets the stage for the Club’s future growth and success, both on and off the field. Benefits of the transaction include: Increased stability across the Club’s shareholder base, which clears the path for future investments, Operational clarity, establishing a unified direction that will allow both players and management to fully concentrate on on-field performance, ensuring that collective focus remains on
Populous Acquires Fentress Architects, Expanding Global Aviation Portfolio6.6.2025 21:00:00 EEST | Press release
Populous, the world-renowned design firm specializing in sport and entertainment venues, today announced the acquisition of Denver-based Fentress Architects, a global leader in iconic aviation projects and prominent public buildings, including convention centers, museums and government facilities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606849000/en/ Los Angeles International Airport. Designed by Fentress Architects. This strategic acquisition unites two of the most respected names in architecture, combining Populous’ unparalleled expertise in designing memorable experiences with Fentress’ award-winning portfolio of aviation, civic and cultural landmarks. The acquisition significantly broadens the scope and scale of services that Populous can offer clients across the globe. Bruce Miller, Populous Global Chair and CEO, commented: “We are committed to expanding the breadth of our practice. Fentress Architects has lon
Vertex Presents New Data on Benefits of ALYFTREK ® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 19:00:00 EEST | Press release
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conference, the Company presented data from a pooled analysis across CFTR modulators, including ALYFTREK, which demonstrate that reduction in sweat chloride (SwCl), and therefore greater restoration of CFTR function, is associated with improved outcomes in people with cystic fibrosis (CF). For all clinical outcomes in the study, SwCl levels below 60 mmol/L were associated with greater benefit
IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10 th Anniversary Year of NAHYCO ® Technology6.6.2025 17:00:00 EEST | Press release
IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the latest innovations and cutting-edge advancements in aesthetic procedures and treatments, staying at the forefront of this dynamic field. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603094257/en/ IBSA’s stand at IMCAS Asia 2025 As part of the congress, IBSA Derma will host a scientific symposium titled “The Future of Tissue Regeneration with NAHYCO® Technology. Feeling and Seeing the Results with Profhilo® Line” scheduled for Saturday, June 7, from 3:00 to 4:00 pm ICT in Room 1 - Level 2. Internationally renowned speakers – Dr. Lam Bee Lan and Prof. Ofir Artzi – will lead
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom